Gabi Schulze-König is the founder of Prevanti and passionately committed to cancer prevention and early detection in the workplace.
As an independent consultant and service provider for employers, she is dedicated to disseminating scientifically sound knowledge about the development, prevention, and early detection of cancer in a way that is easy for employees to understand. Consequently, many people strengthen their health literacy and become sensitized to this socially highly relevant topic. In addition to imparting knowledge, screening services are created, motivating employees to take concrete and active steps toward cancer prevention and early detection. Everyone who engages with the topic becomes a multiplier in their professional and private environments.

In addition to advising employers, Gabi Schulze-König develops individual, tailor-made concepts for them. These form the basis for firmly anchoring the topic of cancer prevention and early detection in the workplace. She plans and organizes specific thematic campaigns and supports employers in their implementation by referring them to the appropriate experts and service providers. This creates a valuable win-win situation for employers and employees.

Gabi Schulze-König studied law at the Universities of Zurich and Rotterdam and has over 10 years of experience as a corporate health manager as well as in-depth knowledge of the design, planning, organization, and implementation of campaigns. The corporate health management program and the cancer prevention and early detection program she developed for the German Cancer Research Center (DKFZ) were awarded the Corporate Health Award and the special “Cancer Prevention” prize in 2024. She has implemented numerous campaigns and screenings with over 5,000 participants at various locations in Germany and has an excellent network and a clear vision of supporting employers in implementing cancer prevention and early detection as part of health management at the highest level. 

She is also an appointed member of the nationwide Corporate Health Committee of EUPD Research.